References
- Jemal A , BrayF, CenterMM, FerlayJ, WardE, FormanD. Global cancer statistics. CA Cancer J. Clin.61(2) , 69–90 (2011).
- Kuiper GG , LemmenJG, CarlssonB et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139(10) , 4252–4263 (1998).
- Pfitscher A , ReiterE, JungbauerA. Receptor binding and transactivation activities of red clover isoflavones and their metabolites. J. Steroid Biochem. Mol. Biol.112(1–3) , 87–94 (2008).
- Takeuchi S , TakahashiT, SawadaY, IidaM, MatsudaT, KojimaH. Comparative study on the nuclear hormone receptor activity of various phytochemicals and their metabolites by reporter gene assays using Chinese hamster ovary cells. Biol. Pharm. Bull.32(2) , 195–202 (2009).
- Muthyala RS , JuYH, ShengS et al. Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorg. Med. Chem. 12(6) , 1559–1567 (2004).
- Perou CM , SorlieT, EisenMB et al. Molecular portraits of human breast tumours. Nature 406(6797) , 747–752 (2000).
- Sorlie T , PerouCM, TibshiraniR et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl Acad. Sci. USA 98(19) , 10869–10874 (2001).
- Wood LD , ParsonsDW, JonesS et al. The genomic landscapes of human breast and colorectal cancers. Science 318(5853) , 1108–1113 (2007).
- Bosviel R , GarciaS, LavediauxG et al. BRCA1 promoter methylation in peripheral blood DNA was identified in sporadic breast cancer and controls. Cancer Epidemiol.36(3) , e177–e182 (2012).
- Adjakly M , BosvielR, RabiauN et al. DNA methylation and soy phytoestrogens: quantitative study in DU-145 and PC-3 human prostate cancer cell lines. Epigenomics 3(6) , 795–803 (2011).
- Kurdistani SK . Histone modifications as markers of cancer prognosis: a cellular view. Br. J. Cancer97(1) , 1–5 (2007).
- Santos-Rosa H , CaldasC. Chromatin modifier enzymes, the histone code and cancer. Eur. J. Cancer41(16) , 2381–2402 (2005).
- Kouzarides T . Chromatin modifications and their function. Cell128(4) , 693–705 (2007).
- Jenuwein T , AllisCD. Translating the histone code. Science293(5532) , 1074–1080 (2001).
- Bernstein BE , KamalM, Lindblad-TohK et al. Genomic maps and comparative analysis of histone modifications in human and mouse. Cell 120(2) , 169–181 (2005).
- Pokholok DK , HarbisonCT, LevineS et al. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 122(4) , 517–527 (2005).
- Schneider R , BannisterAJ, MyersFA, ThorneAW, Crane-RobinsonC, KouzaridesT. Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nat. Cell Biol.6(1) , 73–77 (2004).
- Yoo KH , HennighausenL. EZH2 methyltransferase and H3K27 methylation in breast cancer. Int. J. Biol. Sci.8(1) , 59–65 (2012).
- Tang Y , ZhaoW, ChenY, ZhaoY, GuW. Acetylation is indispensable for p53 activation. Cell133(4) , 612–626 (2008).
- Peterson CL , LanielMA. Histones and histone modifications. Curr. Biol.14(14) , R546–551 (2004).
- Long W , FouldsCE, QinJ et al. ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion. J. Clin. Invest. 122(5) , 1869–1880 (2012).
- Esteller M , SilvaJM, DominguezG et al. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J. Natl Cancer Inst. 92(7) , 564–569 (2000).
- Satih S , RabiauN, BignonYJ, Bernard-GallonDJ. Soy phytoestrogens and breast cancer chemoprevention: molecular mechanisms. Curr. Nutr. Food Sci.4 , 259–264 (2008).
- Cailleau R , YoungR, OliveM, ReevesWJ Jr. Breast tumor cell lines from pleural effusions. J. Natl Cancer Inst.53(3) , 661–674 (1974).
- Soule HD , VazguezJ, LongA, AlbertS, BrennanM. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst.51(5) , 1409–1416 (1973).
- Vissac-Sabatier C , BignonYJ, Bernard-GallonDJ. Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr. Cancer45(2) , 247–255 (2003).
- Yerbes R , Lopez-RivasA. Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL. Invest. New Drugs30(2) , 541–547 (2012).
- Pasqualini JR . The selective estrogen enzyme modulators in breast cancer: a review. Biochim. Biophys. Acta1654(2) , 123–143 (2004).
- Hedlund TE , JohannesWU, MillerGJ. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Prostate54(1) , 68–78 (2003).
- Jackson RL , GreiweJS, DesaiPB, SchwenRJ. Single-dose and steady-state pharmacokinetic studies of S-equol, a potent nonhormonal, estrogen receptor beta-agonist being developed for the treatment of menopausal symptoms. Menopause18(2) , 185–193 (2011).
- Plomley JB , JacksonRL, SchwenRJ, GreiweJS. Development of chiral liquid chromatography-tandem mass spectrometry isotope dilution methods for the determination of unconjugated and total S-equol in human plasma and urine. J. Pharm. Biomed. Anal.55(1) , 125–134 (2011).
- Esteller M . Cancer epigenomics: DNA methylomes and histone-modification maps. Nat. Rev. Genet.8(4) , 286–298 (2007).
- Volkel P , AngrandPO. The control of histone lysine methylation in epigenetic regulation. Biochimie89(1) , 1–20 (2007).
- Wolff MS , WestonA. Breast cancer risk and environmental exposures. Environ. Health Perspect.105(Suppl. 4) , 891–896 (1997).
- Wu AH , YuMC, TsengCC, PikeMC. Epidemiology of soy exposures and breast cancer risk. Br. J. Cancer98(1) , 9–14 (2008).
- Trock BJ , Hilakivi-ClarkeL, ClarkeR. Meta-analysis of soy intake and breast cancer risk. J. Natl Cancer Inst.98(7) , 459–471 (2006).
- Keinan-Boker L , van Der Schouw YT, Grobbee DE, Peeters PH. Dietary phytoestrogens and breast cancer risk. Am. J. Clin. Nutr.79(2) , 282–288 (2004).
- Kondo Y , ShenL, ChengAS et al. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40(6) , 741–750 (2008).
- Bosviel R , DumollardE, DechelotteP, BignonYJ, Bernard-GallonD. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer? OMICS16(5) , 235–244 (2012).
- King-Batoon A , LeszczynskaJM, KleinCB. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ. Mol. Mutagen.49(1) , 36–45 (2008).
- Bosviel R , DurifJ, DechelotteP, BignonYJ, Bernard-GallonD. Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines. Br. J. Nutr.108(7) , 1187–1193 (2012).
- Fang M , ChenD, YangCS. Dietary polyphenols may affect DNA methylation. J. Nutr.137(Suppl. 1) , S223–S228 (2007).
- Hong T , NakagawaT, PanW et al. Isoflavones stimulate estrogen receptor-mediated core histone acetylation. Biochem. Biophys. Res. Commun. 317(1) , 259–264 (2004).
- Zwart W , TheodorouV, KokM, CanisiusS, LinnS, CarrollJS. Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer. EMBO J.30(23) , 4764–4776 (2011).
- Nadal-Serrano M , Sastre-SerraJ, PonsDG, MiroAM, OliverJ, RocaP. The ERalpha/ERbeta ratio determines oxidative stress in breast cancer cell lines in response to 17beta-estradiol. J. Cell Biochem.113(10) , 3178–3185 (2012).
- Strom A , HartmanJ, FosterJS, KietzS, WimalasenaJ, GustafssonJA. Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc. Natl Acad. Sci. USA101(6) , 1566–1571 (2004).